11.24

8.27% -0.91

Tilray Brands Inc (TLRY)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché TLRY Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$12.15

Aprire:

$12.39

Volume 24 ore:

28.70M

Relative Volume:

3.40

Capitalizzazione di mercato:

$1.30B

Reddito:

$829.22M

Utile/perdita netta:

$-248.96M

Rapporto P/E:

-37.47

EPS:

-0.3

Flusso di cassa netto:

$-92.10M

1 W Prestazione:

+54.80%

1M Prestazione:

+3.20%

6M Prestazione:

+175.89%

1 anno Prestazione:

-6.34%

Intervallo 1D:

$10.97

$12.59

Intervallo di 1 settimana:

$7.10

$12.59

Portata 52W:

$3.507

$23.20

Tilray Brands Inc Stock (TLRY) Company Profile

Nome

Tilray Brands Inc

Settore

Healthcare (1126)

Industria

Drug Manufacturers - Specialty & Generic (86)

Telefono

519.322.8800

Indirizzo

655 MADISON AVENUE, NEW YORK

Dipendente

2,842

Cinguettio

@tilray

Prossima data di guadagno

2025-10-09

Ultimi documenti SEC

TLRY's Discussions on Twitter

Confronta TLRY con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
TLRY Tilray Brands Inc	11.25	1.41B	829.22M	-248.96M	-92.10M	-0.30
ZTS Zoetis Inc	120.77	52.29B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	14.54	45.27B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	9.795	42.39B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	30.14	34.18B	16.88B	666.71M	251.19M	0.6132
UTHR United Therapeutics Corp	496.57	21.27B	3.08B	1.24B	1.07B	25.61

Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-04-05	Reiterato	Alliance Global Partners	Neutral
2022-11-02	Iniziato	Bernstein	Mkt Perform
2022-07-29	Downgrade	The Benchmark Company	Hold → Sell
2022-03-04	Aggiornamento	Canaccord Genuity	Hold → Buy
2021-11-18	Iniziato	Barclays	Underweight
2021-11-01	Downgrade	Cantor Fitzgerald	Overweight → Neutral
2021-06-11	Downgrade	CIBC	Sector Outperform → Neutral
2021-06-03	Aggiornamento	Cantor Fitzgerald	Neutral → Overweight
2021-05-11	Ripresa	Cowen	Outperform
2021-05-07	Ripresa	Jefferies	Buy
2021-05-06	Iniziato	Canaccord Genuity	Buy
2021-04-28	Ripresa	BofA Securities	Buy
2021-02-18	Downgrade	Piper Sandler	Overweight → Neutral
2021-02-18	Downgrade	The Benchmark Company	Buy → Hold
2020-11-16	Downgrade	Jefferies	Hold → Underperform
2020-11-11	Downgrade	Stifel	Hold → Sell
2020-10-01	Reiterato	MKM Partners	Neutral
2020-09-21	Aggiornamento	Jefferies	Underperform → Hold
2020-05-12	Reiterato	The Benchmark Company	Buy
2020-04-16	Downgrade	Jefferies	Hold → Underperform
2020-04-09	Downgrade	Consumer Edge Research	Overweight → Equal Weight
2020-02-24	Downgrade	Cowen	Outperform → Market Perform
2020-01-13	Iniziato	BofA/Merrill	Neutral
2019-11-13	Reiterato	The Benchmark Company	Buy
2019-11-05	Iniziato	Cantor Fitzgerald	Neutral
2019-10-22	Reiterato	Piper Jaffray	Overweight
2019-09-20	Iniziato	MKM Partners	Neutral
2019-08-14	Reiterato	The Benchmark Company	Buy
2019-07-17	Iniziato	Ladenburg Thalmann	Neutral
2019-06-28	Iniziato	Consumer Edge Research	Overweight
2019-06-06	Iniziato	Stifel	Hold
2019-06-05	Iniziato	Oppenheimer	Perform
2019-05-15	Aggiornamento	BMO Capital Markets	Underperform → Market Perform
2019-05-13	Iniziato	Alliance Global Partners	Neutral

Mostra tutto

Tilray Brands Inc Borsa (TLRY) Ultime notizie

02:08 AM

What's Going On With Tilray Stock Monday? - Benzinga

02:08 AM

01:35 AM

Tilray CEO says THC drink regulation will benefit cannabis companies - Yahoo Finance

01:35 AM

01:26 AM

Cannabis Stocks To Watch NowDecember 15th - MarketBeat

01:26 AM

12:46 PM

Tilray Brands (NASDAQ:TLRY) Sees Large Volume IncreaseStill a Buy? - MarketBeat

12:46 PM

11:57 AM